Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine S Muli

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Chembiochem : a European Journal of Chemical Biology|December 6, 2023
Discovery and Development of Cyclic Peptide Proteasome StimulatorsSamantha Nelson, Timothy J Harris, Christine S Muli, et al.
Protein Expression and Purification|January 11, 2025
Optimized isolation of enzymatically active ubiquitin E3 ligase E6AP/UBE3A from mammalian cellsJohanna M Schafer, Christine S Muli, Rehab A Heikal, et al.
Molecules (Basel, Switzerland)|March 6, 2021
Optimization and Anti-Cancer Properties of Fluoromethylketones as Covalent Inhibitors for Ubiquitin C-Terminal Hydrolase L1Aaron D Krabill, Hao Chen, Sajjad Hussain, et al.
Journal of Medicinal Chemistry|March 15, 2024
Covalent Fragment Screening and Optimization Identifies the Chloroacetohydrazide Scaffold as Inhibitors for Ubiquitin C-terminal Hydrolase L1Ryan D Imhoff, Rishi Patel, Muhammad Hassan Safdar, et al.
Angewandte Chemie (International Ed. in English)|December 27, 2025
Discovery of a First-in-Class Covalent Allosteric SHP1 Inhibitor with Immunotherapeutic ActivityZihan Qu, Frederick Nguele Meke, Zheng Zhang, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase InhibitorMalcolm P Huestis, Matthew R Durk, Charles Eigenbrot, et al.
Journal of Medicinal Chemistry|March 29, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3<i>H</i>)-quinazolinone Aryl Urea pan-RAF Kinase InhibitorMalcolm P Huestis, Darlene Dela Cruz, Antonio G DiPasquale, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Chembiochem : a European Journal of Chemical Biology|December 6, 2023
Discovery and Development of Cyclic Peptide Proteasome StimulatorsSamantha Nelson, Timothy J Harris, Christine S Muli, et al.
Protein Expression and Purification|January 11, 2025
Optimized isolation of enzymatically active ubiquitin E3 ligase E6AP/UBE3A from mammalian cellsJohanna M Schafer, Christine S Muli, Rehab A Heikal, et al.
Molecules (Basel, Switzerland)|March 6, 2021
Optimization and Anti-Cancer Properties of Fluoromethylketones as Covalent Inhibitors for Ubiquitin C-Terminal Hydrolase L1Aaron D Krabill, Hao Chen, Sajjad Hussain, et al.
Journal of Medicinal Chemistry|March 15, 2024
Covalent Fragment Screening and Optimization Identifies the Chloroacetohydrazide Scaffold as Inhibitors for Ubiquitin C-terminal Hydrolase L1Ryan D Imhoff, Rishi Patel, Muhammad Hassan Safdar, et al.
Angewandte Chemie (International Ed. in English)|December 27, 2025
Discovery of a First-in-Class Covalent Allosteric SHP1 Inhibitor with Immunotherapeutic ActivityZihan Qu, Frederick Nguele Meke, Zheng Zhang, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase InhibitorMalcolm P Huestis, Matthew R Durk, Charles Eigenbrot, et al.
Journal of Medicinal Chemistry|March 29, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3<i>H</i>)-quinazolinone Aryl Urea pan-RAF Kinase InhibitorMalcolm P Huestis, Darlene Dela Cruz, Antonio G DiPasquale, et al.
Pageof 2